• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者的临床前动脉粥样硬化:一项病例对照研究。

Preclinical atherosclerosis in patients with inflammatory bowel diseases: a case-control study.

作者信息

Bruzzese Vincenzo, Palermo Giuseppe, Ridola Lorenzo, Lorenzetti Roberto, Hassan Cesare, Izzo Annamaria, Zullo Angelo

机构信息

Internal Medicine, Rheumatology and Gastroenterology, "Nuovo Regina Margherita" Hospital, Rome, Italy.

Angiology Unit, "Nuovo Regina Margherita" Hospital, Rome, Italy.

出版信息

Ann Transl Med. 2017 Apr;5(7):158. doi: 10.21037/atm.2017.03.68.

DOI:10.21037/atm.2017.03.68
PMID:28480194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5401678/
Abstract

BACKGROUND

An independent role of chronic inflammation in the atherosclerotic process in patients with inflammatory bowel diseases (IBD) has been suggested, but data are still contentious. We assessed pre-clinical atherosclerosis in the IBD patients without traditional risk factors.

METHODS

In this case-control study we assessed the early atherosclerotic alterations by carotid artery intima-media thickness (CIMT) measurement in IBD patients and matched controls. The normal CIMT values were ≤0.9 mm; moderate thickness when >0.9 and ≤1.2 mm, and pre-clinical atherosclerosis when >1.2 mm. We selected a homogeneous group of IBD patients, all in ongoing biologic therapy, without any traditional risk factor for atherosclerosis as well as controls.

RESULTS

The study enrolled 23 consecutive patients (16 with ulcerative colitis and 7 with Crohn's disease) and 20 controls matched for age and sex. The mean of CIMT values was not statistically different between patients and controls (0.68±0.21 . 0.82±0.2 mm; P=0.4). The prevalence of moderate CIMT thickness was significantly lower in cases than in controls (8.7% . 42.8%; P=0.01; OR: 0.15, 95% CI: 0.03-0.85).

CONCLUSIONS

This case-control study found that the atherosclerotic process is not more apparent in IBD patients without traditional risk factors.

摘要

背景

慢性炎症在炎症性肠病(IBD)患者动脉粥样硬化进程中的独立作用已被提出,但数据仍存在争议。我们评估了无传统危险因素的IBD患者的临床前期动脉粥样硬化情况。

方法

在这项病例对照研究中,我们通过测量IBD患者和匹配对照的颈动脉内膜中层厚度(CIMT)来评估早期动脉粥样硬化改变。正常CIMT值≤0.9毫米;厚度>0.9且≤1.2毫米为中度增厚,>1.2毫米为临床前期动脉粥样硬化。我们选择了一组均接受生物治疗、无任何动脉粥样硬化传统危险因素的IBD患者以及对照。

结果

该研究纳入了23例连续患者(16例溃疡性结肠炎患者和7例克罗恩病患者)以及20例年龄和性别匹配的对照。患者和对照的CIMT值均值无统计学差异(0.68±0.21. 0.82±0.2毫米;P = 0.4)。病例组中度CIMT增厚的患病率显著低于对照组(8.7%. 42.8%;P = 0.01;OR:0.15,95%CI:0.03 - 0.85)。

结论

这项病例对照研究发现,在无传统危险因素的IBD患者中,动脉粥样硬化进程并不更明显。

相似文献

1
Preclinical atherosclerosis in patients with inflammatory bowel diseases: a case-control study.炎症性肠病患者的临床前动脉粥样硬化:一项病例对照研究。
Ann Transl Med. 2017 Apr;5(7):158. doi: 10.21037/atm.2017.03.68.
2
Evaluation of epicardial adipose tissue and carotid intima-media thickness as a marker of atherosclerosis in patients with inflammatory bowel disease.评价炎症性肠病患者的心外膜脂肪组织和颈动脉内膜中层厚度作为动脉粥样硬化的标志物。
Rev Esp Enferm Dig. 2021 Sep;113(9):643-648. doi: 10.17235/reed.2020.7394/2020.
3
Endothelial function and cardiovascular risk in active inflammatory bowel diseases.活动性炎症性肠病患者的血管内皮功能与心血管风险。
J Crohns Colitis. 2013 Nov;7(10):e427-33. doi: 10.1016/j.crohns.2013.02.001. Epub 2013 Mar 7.
4
Evaluation of increased subclinical atherosclerosis risk with carotid intima-media thickness and pulse wave velocity in inflamatory bowel disease.炎症性肠病中通过颈动脉内膜中层厚度和脉搏波速度评估亚临床动脉粥样硬化风险增加情况
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:20-5. doi: 10.5152/tjg.2014.5036.
5
Aortic Intima-Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease.主动脉内膜中层厚度作为炎症性肠病患儿动脉粥样硬化的早期标志物
J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):41-6. doi: 10.1097/MPG.0000000000000771.
6
Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data.炎症性肠病与颈动脉内膜中层厚度之间存在关联吗?初步数据。
Angiology. 2014 Jul;65(6):543-50. doi: 10.1177/0003319713489876. Epub 2013 Jun 6.
7
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.炎症性肠病患者早期动脉粥样硬化标志物表达增加。
Eur J Intern Med. 2017 Jan;37:83-89. doi: 10.1016/j.ejim.2016.10.004. Epub 2016 Oct 21.
8
Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease.炎症性肠病患者早期动脉粥样硬化标志物的评估
Med Sci Monit. 2016 Oct 24;22:3943-3950. doi: 10.12659/msm.898160.
9
Pulse Wave Velocity, Intima Media Thickness, and Flow-mediated Dilatation in Patients with Normotensive Normoglycemic Inflammatory Bowel Disease.血压正常、血糖正常的炎症性肠病患者的脉搏波速度、内膜中层厚度和血流介导的血管舒张功能
Inflamm Bowel Dis. 2015 Jun;21(6):1314-20. doi: 10.1097/MIB.0000000000000355.
10
Epicardial Adipose Tissue Is Increased in Patients With Inflammatory Bowel Disease.炎症性肠病患者的心外膜脂肪组织增加。
J Ultrasound Med. 2016 Sep;35(9):1859-64. doi: 10.7863/ultra.14.09040. Epub 2016 Jul 14.

引用本文的文献

1
Argan Fruit Polyphenols Regulate Lipid Homeostasis, Prevent Liver Fat Accumulation, and Improve Antioxidant Defense in High-Calorie Diet Fed Mice: In Vivo Study and In Silico Prediction of Possible Underlying Mechanisms.阿甘油果多酚调节高脂饮食喂养小鼠的脂质稳态、预防肝脏脂肪堆积并改善抗氧化防御:体内研究及潜在机制的计算机模拟预测
Metabolites. 2025 Mar 28;15(4):234. doi: 10.3390/metabo15040234.
2
Inflammatory bowel disease patients have an increased risk of acute coronary syndrome: a systematic review and meta-analysis.炎症性肠病患者发生急性冠状动脉综合征的风险增加:系统评价和荟萃分析。
Open Heart. 2023 Nov;10(2). doi: 10.1136/openhrt-2023-002483.
3
Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.炎症性肠病患者的内皮功能障碍与动脉僵硬度:一项系统评价和荟萃分析
J Clin Med. 2022 Jun 2;11(11):3179. doi: 10.3390/jcm11113179.

本文引用的文献

1
Recent advances in pathogenesis, assessment, and treatment of atherosclerosis.动脉粥样硬化发病机制、评估及治疗的最新进展
F1000Res. 2016 Jul 28;5. doi: 10.12688/f1000research.8459.1. eCollection 2016.
2
Prediction of cardiovascular outcomes by imaging coronary atherosclerosis.通过冠状动脉粥样硬化成像预测心血管结局
Cardiovasc Diagn Ther. 2016 Aug;6(4):322-39. doi: 10.21037/cdt.2015.12.08.
3
Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.炎症性肠病患者的亚临床动脉粥样硬化:一项系统评价和荟萃分析。
Angiology. 2017 May;68(5):447-461. doi: 10.1177/0003319716652031. Epub 2016 Jun 1.
4
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase.缓解期炎症性肠病患者的内皮功能与心血管风险
Scand J Gastroenterol. 2016;51(2):253-5. doi: 10.3109/00365521.2015.1070901. Epub 2015 Jul 25.
5
Rheumatoid arthritis and cardiovascular risk: between lights and shadows.
Curr Rheumatol Rev. 2013;9(2):100-4. doi: 10.2174/1573397111309020004.
6
Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease.类风湿关节炎与炎症性肠病的炎症、动脉僵硬与传统心血管危险因素比较。
J Inflamm (Lond). 2014 Oct 11;11(1):29. doi: 10.1186/s12950-014-0029-0. eCollection 2014.
7
Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease.炎症性肠病合并确诊冠心病患者的传统危险因素及心血管结局
Inflamm Bowel Dis. 2014 Sep;20(9):1593-601. doi: 10.1097/MIB.0000000000000109.
8
Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis.炎症性肠病患者发生脑血管意外和缺血性心脏病的风险:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2014 Mar;12(3):382-93.e1: quiz e22. doi: 10.1016/j.cgh.2013.08.023. Epub 2013 Aug 24.
9
Endothelial function and cardiovascular risk in active inflammatory bowel diseases.活动性炎症性肠病患者的血管内皮功能与心血管风险。
J Crohns Colitis. 2013 Nov;7(10):e427-33. doi: 10.1016/j.crohns.2013.02.001. Epub 2013 Mar 7.
10
Are patients with inflammatory bowel disease at increased risk of coronary artery disease?炎症性肠病患者患冠状动脉疾病的风险是否增加?
Am J Med. 2012 Oct;125(10):956-62. doi: 10.1016/j.amjmed.2012.03.015. Epub 2012 Jul 25.